Endothelin-1 (ET-1), a 21-amino acid vasoconstrictive peptide, increases intracellular Ca2' level and has hypertrophic action on ventricular myocytes. To elucidate a possible role of Ca2+ entry through sarcolemmal Ca2+ channels on this ET-1 action, we examined effects of ET-1 on L-type (ICa,L) and T-type (ICaT) Ca2+ currents in cultured neonatal rat ventricular myocytes using the patch-clamp technique. ET-1 at a concentration of 10 nM increased the maximum current density of ICa,T from -3.0± 1.4 pA/cm2 in the control condition to -4.4+ 1.6 gA/cm2 (p<0.01). Although the peak amplitude of IC8,L was decreased during ET-1 application (from -9.7±+1.9 ,gA/cm2 in the control condition to -5.0± 
bathing the primary cultures of porcine aortic endothelial cells.' This endothelium-derived vasoconstrictive peptide induces a potent and sustained vasoconstrictive effect on a variety of blood vessels and may play an important role in the regulation of blood pressure and local blood flow.' ET-1 has been shown to have specific receptors on the sarcolemma of cardiac myocytes, to increase the intracellular Ca21 level ([Ca2+] i),2 and to act as a positive inotropic agent in mammalian atrial and ventricular muscle.34 Recently, we have reported that ET-1 induces hypertrophy with concomitant increases in the transcripts of musclespecific genes and a proto-oncogene, c-fos, as well as DNA and protein synthesis in cultured neonatal rat ventricular myocytes. 5 The mechanism by which ET-1 induces a positive Figure 1A ), whereas voltage steps from -50 mV activated only 1Ca,L (middle tracings in 1CaT (bottom tracings in Figure 1A ). The current amplitude was measured by subtracting the current at the end of the voltage step from the initial inward peak. Figure   1B shows current density-voltage relations of total 1Ca
glass pipettes with a diameter of 1-2 gm. We also studied the effect of ET-1 on ICa,L. It is well known that the amplitude of 1CaL decreases spontaneously after establishment of the whole-cell clamp configuration ("run-down"),12 whereas the fluctuation pattern of the amplitude of 1CaT is relatively unknown. Recently, Tseng and Boyden13 reported that
ICaT showed "run-up," which stabilized approximately 10 minutes after establishment of the whole-cell clamp configuration. To determine whether the increase in ICa,T after the addition of ET-1 was due to the run-up phenomenon or to the specific effect of ET-1, we recorded ICaT without addition of ET-1 in five cells (left graph in Figure 7A ). The Figure 7B ) and in the presence of BSA in four cells (left graph in Figure 7C ). The current density of 1CaT in the control state (at 10 minutes after establishment of the whole-cell configuration) and 20 minutes after the addition of heat-denatured ET-1 (10 nM) (left graph in Figure 7B ) or BSA (20 nM) (left graph in Figure 7C ) is plotted against V,. In either case, the maximum current density of IC,T was not significantly changed from the control values, but the voltage for the activation sequence or the maximum activation shifted :10 mV in the negative direction with time. These findings appear to suggest that the enhancement of 1CaT by ET-1 was due to the specific effect of ET-1, whereas the shift in the voltage dependence of 1CaT activation appears to be due to nonspecific effects of perfusion with peptides.
To test whether the specific action of ET-1 was responsible, at least in part, for the decrease in the amplitude of 1CaL, we also recorded ICa,L for 20 minutes without the addition of ET-1 in five cells (right graph in Figure 7A ), after addition of heat-denatured 10 nM ET-1 (right graph in Figure 7B ), and after the addition of 10 nM BSA (right graph in Figure 7C ). When ET-1 (10 nM) was applied to the bath solution, the amplitude of Ca,L 20 minutes after ET-1 application was decreased to 52±19% of the control value (see Figure 6B ). When We also tested the effect of ET-1 on 1Ca,T at a temperature of 34-36°C. Figure 8A displays the current density-voltage relations in the control state and 20 minutes after the addition of ET-1 (10 nM) (n=5). At a temperature of 34-36°C, the maximum amplitude of 1CaT after the addition of ET-1 increased from the control value of -3.2+0.8 pA/cm2 to -4.3 +0. 6 ,gA/cm2 after the addition of ET-1 (p<0.01). Furthermore, we also tested the effect of ET-1 on Ba21 current through T-type channels (n =4, Figure 8B ) and its effect on ICa,T in the presence of 0.2 ,uM nisoldipine, a blocker of 1CaL (n=4, Figure 8C ). In the former case, the kinetics of Ba2+ currents through T-type and L-type channels are distinctly different, making it easy to separate these two currents. In the latter case, 1Ca,L was blocked by nisoldipine almost completely (see Figure 3) ; thus, 1Ca,T could be obtained without interference by lCa,L. In both cases, the addition of ET-1 still enhanced the maximum current density through T-type Ca2+ channels. The maximum Ba2+ current density through T-type channels was -3.4+0.5 gA/cm2 in the control state and -4.5+0.7 ,A/cm2 after the addition of 10 nM ET-1 (p<O.Ol). For 1Ca,T in the presence of nisoldipine (0.2 ,uM), it was -3.1 +±1.5 ,gA/cm2 in the control state and -4.2+ 1.2 pA/cm2 after the addition of ET-1 (p<0.01).
To examine the relation between the concentration of ET-1 and the magnitude of enhancement of ICa,T carried by Ca2 , we tested the effect of ET-1 on the amplitude of 1CaT at concentrations of 0.01, 0.1, 0.32, 1, 3.2, 10, and 100 nM ( Figure 9 ). Representative tracings of 1CaT at -30 mV before and after the addition of ET-1 at concentrations of 0.1, 1, and 10 nM are shown in Figure  9A . A concentration-response curve was constructed from 40 pooled data measurements (four to 11 measure- ments for each point) ( Figure 9B ). The dose-response relation between the concentration of ET-1 and the percent increment in the lCaT amplitude was fitted to the Hill equation using a least-squares method with the assumption of the Hill coefficient being 1:
where A is the maximum response, K1 is the EC50 value, and n is the Hill coefficient, which is assumed to be 1 in this case. The concentration of ET-1 that produced a half-maximal enhancement of 1CaT (EC50) was 1.26 nM.
The enhancement of 1CaT appeared to achieve its maximum response at a concentration of 10 nM, and the maximal percent increment of 1CaT was 54%. Figure 10 (n=11). The time constant showed U-shaped voltage dependence, with a minimum value at -10 mV in the control state. The addition of ET-1 (10 nM) did not significantly change the time constant but shifted its voltage dependence 10 mV in a negative direction. The minimum time constant of decay of ICa,T was 11.2±+2.1 msec at -10 mV in the control condition and 12.5+1.0 msec at -20 mV after the addition of ET-1 (p=NS).
Effects of ET-i

Effect of Protein Kinase C Inhibitors
In vascular smooth muscle cells, the binding of ET-1 to its sarcolemmal receptor is known to increase the activity of intracellular protein kinase C through a pathway involving GTP-binding protein.14 In the follow- ing series of experiments, we examined whether or not the activation of protein kinase C was also involved in the enhancement of 1Ca,T by ET-1 in neonatal ventricular myocytes. In the first series of experiments, we studied the effect of protein kinase C inhibitor staurosporine (0.2 juM)15 on the enhancement of 1CaT by ET-1. The mean current density-voltage relations of 1CaT from four cells in the control condition and 20 minutes after addition of ET-1 (10 nM) in the experiments using pipette solution containing 0.2 ,uM staurosporine are plotted in Figure 11A . However, the increase in the peak amplitude of 1CaT did not show a statistically significant change. The maximum current density of 1Ca,T was -4.5+±1.0 MA/cm2 in the control condition and -4.7± 1.3 pA/cm2 after the addition of 10 nM ET-1 (p=NS).
We also tested the effect of protein kinase C inhibitor H-7 (20 ,uM)'6 on the enhancement of 1CaT by ET-1. The current density-voltage relations in the control state and 20 minutes after the addition of ET-1 (10 nM) using pipette solution containing 20 [uM H-7 are plotted in (,uA/cm ) -3.3+0.9 gA/cm2 after the addition of 10 nM ET-1 (p=NS).
Effects of Protein Kinase C Activation on ICa,T Since both inhibitors of protein kinase C that were used (staurosporine and H-7) are known to inhibit other classes of serine/threonine-type protein kinases,1617 the elimination of ET-1 action by these agents is not sufficient to conclude that ET-1 action on ICaT was via a pathway involving the activation of protein kinase C. Thus, we next examined the effects of tumor-promoting phorbol esters that are known to cause the activation of protein kinase C both in vitro and in intact cells.'8 The mean current density-voltage relations of 1CaT from six cells in the control condition and 20 minutes after the addition of 0.2 ,M PDBu are shown in Figure 12A . Similar to the effect of ET-1, the maximum amplitude of 1Ca,Twas increased from -4.2±0.5 ptA/cm2 in the control condition to -5.5±1.0 gA/cm2 after the addition of 0.2 ,M PDBu. The addition of another type of phorbol ester (PMA) also increased the peak amplitude of 1CaT (n=3, data not shown). Figure 12B displays the effect of the addition of PDBu (0.2 ,uM) on ICaT in the presence of 20 ,M H-7 in the pipette solution (n=4). In the presence of 20 ,uM H-7, the addition of PDBu (0.2 ,uM) did not increase the maximum current density of 1CaT; the maximum current density of Ca,T was -4.7±0.9 MiA/cm' in the control condition and -4.4±0.9 ,gA/cm' after the addition of PDBu (p=NS). We also tested the effect of the 4a isomer of PDBu (4a-PDBu, 0.2 jtM) on 1CaT ( Figure   12C , n=4), which is inactive in stimulating protein kinase C.'9 The addition of 4a-PDBu did not increase the maximum current density of 1Caj; the maximum current density of ICa,T was -4.1±0.9 ,tA/cm2 in the control condition and -3.5±0.6 MA/cm' after the addition of 0.2 gM PDBu (p=NS). These findings further indicate that the effect of PDBu on 1CaT enhancement was due to a specific effect of PDBu on stimulating protein kinase C rather than to its nonspecific effects.
Effect of GTP on ET-i Action
As stated earlier, ET-1-induced vasoconstriction in vascular smooth muscle cells is known to act through increasing the activity of intracellular protein kinase C, and this action is mediated through a pathway involving the GTP-binding protein. get some insight whether this stimulating action of protein kinase C also involves the GTP-binding protein in neonatal ventricular myocytes, we tested the effects of ET-1 on 1CaT in the absence of GTP in the pipette solution. Figure 13 displays the mean current densityvoltage relations of 1CaT from four cells in the control condition and 20 minutes after the addition of ET-1 (10 nM), when GTP was omitted from the pipette solution. In the absence of GTP, ET-1 failed to enhance the amplitude of ICa,T; the maximum current density of 1CaT was -2.7±0.6 gA/cm2 in the control condition and -2.5 +0.5 gA/cm2 20 6 Furthermore, the dose-response relation for the induction of hypertrophy by ET-1 in neonatal cultured rat ventricular myocytes appeared to be similar. 5 Effects of ET-1 on muscle-specific gene expression and on the synthesis of protein and DNA were initiated at a dose >0.1 nM and attained the maximal effect at a concentration of 10 nM. 5 Augmentation of 1CaT induced by ET-1 appears to act through the activation of protein kinase C. Inclusion of staurosporine or H-7 in the intracellular solution incompletely, but to a substantial extent, antagonized the action of ET-1 on 1CaT. At this concentration, staurosporine is reported to inhibit the action of several classes of serine/threonine protein kinases, including protein kinase C, cAMP-dependent protein kinase, cGMP-dependent protein kinase, and Ca 2+ /calmodulin-dependent protein kinase 11.17 H-7 at this concentration also inhibits both protein kinase C and cAMPdependent protein kinase.16 Thus, antagonistic action of these agents may not be sufficient to conclude that protein kinase C is involved. Stimulation by tumorpromoting phorbol esters PDBu and PMA enhanced the peak amplitude of 1CajT Although we have not directly measured protein kinase C activity, it is generally agreed that phorbol esters, like diacylglycerol, bind to the protein kinase C-phospholipid complex to cause stimulation of the enzyme. 18 The stimulating effect by phorbol esters was prevented when H-7 was present in the pipette solution. Furthermore, the 4a isomer of PDBu (4a-PDBu), an inactive form of phorbol ester,19 failed to enhance 1CaT. Therefore, we speculate that protein kinase C activation mediates the enhancement of Ca,T induced by ET-1. The effects of the activation of protein kinase C on both 1CaL and 1CaT are currently controversial. Leatherman Tseng and Boyden26 used ventricular and Purkinje cells freshly isolated from adult dogs; we used neonatal rat ventricular cells cultured for 4 days. Thus, the different findings may be due to an age-dependent action of protein kinase C, species difference, or altered properties after cell culture. It is also possible that the different findings were due to the different pipette solutions used. Tseng and Boyden26 used a pipette solution containing no GTP; we used a pipette solution containing 0.2 mM GTP. In our study, when GTP was omitted from the pipette solution, ET-1 failed to augment 1CaT, suggesting the possibility of an involvement of GTP-binding protein in the ET-1 action on 1CaT. Since data on the involvement of GTP-binding protein in ET-1-induced augmentation of Ca,T are limited in the present experiment, further studies are needed to confirm this hypothesis and to determine which GTP-binding protein is responsible.
Identification and pursuit of growth signals that trigger the expression of proto-oncogenes, which in turn direct the characteristic increase in protein synthesis, have been sought for years and remain to be settled. There is a compelling body of data suggesting that the increase in [Ca21]i constitutes the crucial link between the initial stimulus for hypertrophy, such as elevated perfusion pressure and growth hormone, and the alterations in gene expression (see the review by Marban and Koretsune27). Xu and Best28 recently have demonstrated a threefold increase in the density of 1CaT in atrial myocytes obtained from young adult rats bearing growth hormone-secreting tumors. Therefore, it seems plausible that the enhancement of Ca,T may play a key role in the genesis of cardiac hypertrophy at least in the model in which hypertrophy is induced by stimulation of the sarcolemmal receptor of cardiac myocytes, although a further investigation is necessary to specify its exact role in hypertrophism.
